Study on the Efficacy of Shugan Jieyu Capsules Combined with Trazodone in Patients with Post-Stroke Depression and Insomnia
Download PDF

Keywords

ShuGan JieYu capsules
Trazodone
Stroke
Depression
Insomnia

DOI

10.26689/jcnr.v8i2.6168

Submitted : 2024-01-27
Accepted : 2024-02-11
Published : 2024-02-26

Abstract

Objective: To analyze the effectiveness of applying ShuGan JieYu Capsules (SGJYC) combined with trazodone in patients with post-stroke depression (PSD) with insomnia. Methods: 60 cases of PSD with insomnia patients admitted to the hospital from May 2022 to May 2023 were selected and randomly divided into a reference group (trazodone) and a research group (SGJYC combined with trazodone) of 30 cases each. Statistics were analyzed using the Hamilton Depression Rating Scale (HAM-D), Pittsburgh Sleep Quality Index (PSQI), and Activities of Daily Living (ADL) scale before treatment and 4, 8, and 12 weeks after treatment. Results: Before treatment, The results of HAM-D, PSQI, and ADL scale studies in the two groups before treatment were not statistically significant (P > 0.05); 4, 8, and 12 weeks after treatment, the results of HAM-D and PSQI studies in the research group were lower than that of the reference group, and the results of ADL scale studies were higher than that of the reference group. There was a significant difference between the groups (P < 0.05). The total adverse reaction rate of the research group was lower than that of the reference group, and there was a significant difference between the groups (P < 0.05). Conclusion: The combination of SGJYC and trazodone reduced depression in post-stroke patients, corrected insomnia, improved sleep quality, was safe, and had a low rate of adverse reactions.

References

Liu L, Li X, Zhang X, et al., 2022, Effect of Duloxetine Hydrochloride Combined with Trazodone Hydrochloride in the Treatment of Anxiety-Depression Co-Morbid State after Ischemic Stroke. Journal of Clinical and Experimental Medicine, 21(20): 2155–2159.

Cao W, Li D, Pei C, et al., 2022, Clinical Effects of Repetitive Transcranial Magnetic Stimulation Combined with Trazodone in the Treatment of Patients with Post-Stroke Depression with Sleep Disorder. Journal of Practical Hospital Clinics, 19(6): 165–168.

Pang Q, Zhao Y, Shao S, et al. Therapeutic Efficacy of Dorsal Yu Acupoint Embedding Combined with Shu Hepatic Relief Capsule in the Treatment of Post-Stroke Depression. Shanghai Journal of Acupuncture and Moxibustion, 41(2): 128–133.

Huang D, 2022, Observation of the Clinical Efficacy of Repetitive Transcranial Magnetic Stimulation on Insomnia Patients with Ischemic Stroke. World Journal of Sleep Medicine, 9(2): 209–211.

Lam CW, Li HJ, Guo J, et al., 2023, Acupuncture for Post-Stroke Depression: A Systematic Review and Network Meta-Analysis. BMC Psychiatry, 23(1): 314.

Chen Y, 2022, Observation on the Therapeutic Effect of Activating Blood Circulation and Tranquilizing Spirit Soup in Treating Insomnia with Blood Stasis and Internal Obstruction after Ischemic Stroke. Journal of Practical Chinese Medicine, 38(8): 1298–1299.

Expert Group of the Chinese Society of Traditional Chinese Medicine, Psychosomatic Medicine Branch, 2021, Expert Consensus on the Clinical Application of Shugan Jieyu Capsules in the Treatment of Mild-to-Moderate Depressive Disorders. Journal of Beijing University of Chinese Medicine, 44(11): 969–977.

Zhu M, Pan G, Luo F, et al., 2023, Modified Suanzaoren Decoction in Treating Post-Stroke Cognitive Impairment with Comorbid Insomnia Symptoms: A Clinical Trial. Medicine (Baltimore), 102(40): e35239.

Wang H, Mao S, Wang P, 2023, Research Progress on the Pathogenesis and Risk Factors of Post-Stroke Depression. Journal of Stroke and Neurological Diseases, 40(9): 785–788.

Zhao Y, Li Y, Wang D, et al., 2022, Evaluation of Antidepressant Efficacy Markers and Mechanisms of Shugan Jieyu Capsules. Chinese Journal of Behavioral Medicine and Brain Science, 31(3): 235–240.

Yu X, Huang Z, Zhu Z, 2022, Clinical Efficacy of Shu Hepatic Decongestant Capsule Combined with Escitalopram and Agomelatine in the Treatment of Middle-Aged and Elderly Patients with Depression Accompanied by Insomnia. Journal of Clinical and Experimental Medicine, 21(8): 800–803.

Zhu N, Duan Y, Wang N, et al., 2022, Research on the Effect of Rational-Emotional Behavioral Therapy on Sleep and Mood of Depressed Patients after Stroke. Chinese Family Medicine, 25(12): 1481–1486.